Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesActive in the last 2 years

Steven Neema Seyedin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6841-968X; OpenAlex author ID A5069486509. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning Approach. Last author DOI 10.1002/cam4.71447↗
  2. Effect of socioeconomic status on surgery for pancreatic adenocarcinoma. Co-author DOI 10.1177/000313481207801026↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jennifer Brooke Valerin · 1 shared paper, 2025 · strength 0.25
  2. Farshid Dayyani · 1 shared paper, 2025 · strength 0.25
  3. David K. Imagawa · 1 shared paper, 2025 · strength 0.25
  4. Garrett K. Harada · 1 shared paper, 2025 · strength 0.25
  5. Zeljka Jutric · 1 shared paper, 2025 · strength 0.25
  6. David S. Hong · 1 shared paper, 2025 · strength 0.25
  7. Byrne Lee · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.